I. Das et al. / Carbohydrate Research 343 (2008) 1287–1296
1293
3H), 3.32 (s, 3H), 3.35–3.43 (m, 3H), 3.72 (m, 1H), 4.47
(d, J = 1.3 Hz, 2H), 4.60 (m, 1H), 4.83 (d, J = 4.4 Hz,
1H), 7.26–7.30 (m, 7H), 7.76 (d, J = 8.3 Hz, 2H). 13C
NMR (CDCl3): d 21.6, 24.8, 24.9, 25.8, 33.2, 34.3,
54.7, 55.7, 61.4, 68.9, 73.1, 76.1, 102.9, 127.6, 127.7,
128.2, 128.7, 129.5, 135.6, 137.8, 144.8. Anal. Calcd
for C26H35NO5S: C, 65.93; H, 7.45; N, 2.96. Found:
C, 66.24; H, 7.78; N, 3.04.
inseparable mixture of two anomers 9 (2.7 g, 89%)
following the general procedure. Eluent: 1:5 EtOAc–
petroleum ether. Yellow gum. Compound 9 (2.0 g,
5.26 mmol) was converted to 10 and 11 (2.0 g, 91%)
following the general procedure. The anomeric mixture
can be separated at this stage (10:11 = 1:4). Compound
10: (0.33 g, 15%). Eluent: 1:3 EtOAc–petroleum ether.
29
White crystalline solid. Mp 116 °C. ½aꢁD +131.4 (c 0.1,
CHCl3). 1H NMR (CDCl3): d 1.41–1.57 (m, 10H),
2.44 (s, 3H), 3.47 (s, 3H), 3.87 (dd, J = 5.1, 18.9 Hz,
1H), 4.05–4.13 (m, 2H), 4.29–4.37 (m, 2H), 4.79 (m,
1H), 4.92 (d, J = 4.5 Hz, 1H), 7.34 (d, J = 8.0 Hz, 2H),
7.83 (d, J = 8.3 Hz, 2H). 13C NMR (CDCl3): d 21.4,
23.3, 23.7, 24.9, 33.6, 35.6, 55.0, 63.4, 64.3, 72.4, 77.4,
77.5, 101.6, 110.1, 128.22, 129.4, 137.6, 144.5. Anal.
Calcd for C20H28O7S: C, 58.24; H, 6.84. Found: C,
57.93; H, 7.06. Compound 11: (1.5 g, 69%). Eluent: 1:3
EtOAc–petroleum ether. White crystalline solid. Mp
3.12. Methyl 5-O-benzyl-2,3-dideoxy-2-pyrrolidino-(3-C-
p-tolylsulfonyl)-b-D-arabinofuranoside (6d)
Compound 4 (0.19 g, 0.51 mmol) was converted to 6d
following the general procedure (0.2 g, 86%). Eluent:
1:3 EtOAc–petroleum ether. White crystalline solid.
29
Mp 149 °C. ½aꢁD ꢃ84.9 (c 0.22, CHCl3). 1H NMR
(CDCl3): d 1.68 (br m, 4H), 2.41 (s, 3H), 2.65 (br m,
2H), 2.81 (br m, 2H), 3.32 (s, 3H), 3.34–3.46 (m, 2H),
3.79–3.81 (m, 2H), 4.37 (d, J = 4.6 Hz, 2H), 4.52 (m,
1H), 4.95 (d, J = 4.1 Hz, 1H), 7.17–7.32 (m, 7H), 7.74
(d, J = 8.2 Hz, 2H). 13C NMR (CDCl3): d 21.5, 23.3,
50.5, 54.9, 64.8, 65.4, 72.6, 72.9, 77.4, 105.1, 127.5,
128.1, 128.7, 129.5, 135.2, 137.7, 144.7. Anal. Calcd
for C24H31NO5S: C, 64.69; H, 7.01; N, 3.14. Found:
C, 65.03; H, 6.73; N, 3.20.
29
1
74 °C. ½aꢁD ꢃ67.5 (c 0.26, CHCl3). H NMR (CDCl3):
d 1.38–1.56 (m, 10H), 2.46 (s, 3H), 3.31 (s, 3H), 3.77
(dd, J = 4.9, 15.5 Hz, 1H), 3.89–4.19 (m, 3H), 4.26 (d,
J = 5.1 Hz, 1H), 4.72 (dd, J = 6.1, 14.5 Hz, 1H), 4.84
(d, J = 0.6 Hz, 1H), 7.36 (d, J = 7.9 Hz, 2H), 7.85 (d,
J = 8.3 Hz, 2H). 13C NMR (CDCl3): d 21.4, 23.5, 23.7,
24.9, 34.4, 35.7, 54.9, 65.5, 67.5, 75.9, 76.8, 78.4, 108.4,
110.3, 128.3, 129.6, 136.1, 145.1. Anal. Calcd for
C20H28O7S: C, 58.24; H, 6.84. Found: C, 58.10; H, 6.94.
3.13. Methyl 5-O-benzyl-2,3-dideoxy-2-morpholino-(3-
C-p-tolylsulfonyl)-b-D-arabino- and xylofuranoside (6e
and 6e0)
3.15. Methyl 5,6-O-cyclohexylidene-2,3-dideoxy-(3-C-p-
tolylsulfonyl)-a-D-erythro-hex-2-enopyranoside (12)
Compound 4 (0.27 g, 0.72 mmol) was converted to 6d
and 6d0, an inseparable mixture of two diastereomers
following the general procedure (0.25 g, 76%). Eluent:
1:2 EtOAc–petroleum ether. Amorphous solid.
Compound 10 (1.2 g, 2.91 mmol) was converted to 12
following the general procedure (0.97 g, 84%). Eluent:
29
1:5 EtOAc–petroleum ether. Yellow gum. ½aꢁD ꢃ5.8 (c
0.64, CHCl3). 1H NMR (CDCl3): d 1.40–1.66 (m,
10H), 2.46 (s, 3H), 3.35 (s, 3H), 3.64 (m, 1H), 3.86 (m,
1H), 4.49 (m, 1H), 5.12 (m, 1H), 5.81 (d, J = 4.5 Hz,
1H), 6.52 (m, 1H), 7.37 (d, J = 8.1 Hz, 2H), 7.81 (d,
J = 8.1 Hz, 2H). 13C NMR (CDCl3): d 21.6, 23.7, 23.8,
25.0, 34.6, 35.4, 54.7, 63.6, 75.4, 83.0, 106.9, 110.6,
128.2, 130.1, 135.6, 136.6, 145.5, 147.8. Anal. Calcd for
C20H26O6S: C, 60.89; H, 6.64. Found: C, 60.85; H, 6.48.
3.14. Methyl 5,6-O-cyclohexylidene-3-deoxy-(3-C-p-
tolylsulfonyl)-a-D-allopyranoside (10) and methyl 5,6-
O-cyclohexylidene-3-deoxy-(3-C-p-tolylsulfonyl)-b-D-
allopyranoside (11)
Compound 7 (5.0 g, 12.06 mmol) was gently heated un-
der reflux at 80 °C with cyclohexanone (1.2 mL/mmol),
MeOH (60 mL), and concd H2SO4 (0.1 mL) for
2.5 h.13 After completion of the reaction (TLC), toluene
(30 mL) was added, and the mixture was cooled to room
temperature. MeOH was evaporated to dryness under
reduced pressure to get a residue. The residue was neu-
tralized with Et3N, and the mixture was diluted with
EtOAc (40 mL), washed with satd aq NaHCO3, and
then with H2O. The combined organic layers were dried
over anhyd Na2SO4 and filtered, and the filtrate was
concentrated under reduced pressure to get a gummy
residue. The residue was purified over a silica gel column
(eluent: 1:1 EtOAc–petroleum ether) to obtain an insep-
arable mixture of two anomers 8 (3.4 g, 65%). The ano-
meric mixture 8 (3.4 g, 7.93 mmol) was converted to an
3.16. Methyl 5,6-O-cyclohexylidene-2,3-dideoxy-(3-C-p-
tolylsulfonyl)-b-D-erythro-hex-2-enopyranoside (13)
Compound 11 (1.8 g, 4.36 mmol) was converted to 13
following the general procedure (1.4 g, 82%). Eluent:
1:5 EtOAc–petroleum ether. White crystalline solid.
29
Mp 84 °C. ½aꢁD ꢃ172.0 (c 0.04, CHCl3). 1H NMR
(CDCl3): d 1.40–1.64 (m, 10H), 2.46 (s, 3H), 3.45 (s,
3H), 3.70 (dd, J = 6.9, 16.6 Hz, 1H), 3.92 (dd, J = 5.9,
16.8 Hz, 1H), 4.39 (m, 1H), 5.02 (m, 1H), 5.66 (m,
1H), 6.52 (m, 1H), 7.36 (d, J = 7.9 Hz, 2H), 7.79 (d,
J = 8.4 Hz, 2H). 13C NMR (CDCl3): d 21.6, 23.7,
23.9, 25.1, 34.7, 35.7, 56.2, 63.7, 75.4, 83.6, 107.1,